Qualitative Transcriptional Signature for Predicting the Pathological Response of Colorectal Cancer to FOLFIRI Therapy
Jun He, Mengyao Wang, Dandan Wu, Hao Fu, Xiaopei Shen, Massimo Nabissi · 2024
Read Qualitative Transcriptional Signature for Predicting the Pathological Response of Colorectal Cancer to FOLFIRI Therapy by Jun He, Mengyao Wang, Dandan Wu, Hao Fu, Xiaopei Shen, Massimo Nabissi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641733.txt.
Description
Jun He and co-authors built a gene-based test to predict response to a standard chemotherapy mix in a 2024 paper. The mix, called FOLFIRI, is a first-line treatment for colorectal cancer that has spread, but fewer than half of patients respond. A way to spot likely responders in advance would spare others harsh side effects.
The team's signature rests on just three pairs of genes, judged by which member of each pair is more active. It sorted patients with 94 percent accuracy in training data. In two check sets, patients flagged as responders lived longer without their cancer growing. The signature genes also link to immune activity, hinting at why the mix works when it does.
Catalog record
| CREATOR | Jun He, Mengyao Wang, Dandan Wu, Hao Fu, Xiaopei Shen, Massimo Nabissi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |